Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SME3110 (Fluvoxamine) in Pediatric OCD
NCT00352768Phase 4Terminated
- Sponsor
- Solvay
- Start
- Aug 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluvoxamine in obsessive compulsive disorder (OCD), sponsored by Solvay. Started Aug 2006; status: terminated.
02
Drugs
fluvoxamine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00352768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00352768.